Bond S J
Department of Surgery, University of Louisville School of Medicine, KY 40292.
J Ky Med Assoc. 1992 May;90(5):242-9.
The advent of improved obstetrical care and innovative advances in fetal diagnostic techniques have mandated multidisciplinary approaches to pregnancies that are complicated by prenatally diagnosed defects. The concept of fetal therapy, previously limited to in utero transfusions for Rh disease and induction of lung maturation, has now been extended to open fetal correction of congenital hydronephrosis, diaphragmatic hernia, and sacrococcygeal teratoma. Additional inquiries are now being made into the possibility of hematopoietic stem cell transplantation in utero as well as prenatal gene therapy. Continued investigation into these therapeutic interventions largely revolves around improving their efficacy and guaranteeing the safety of the mother and her unborn child.
产科护理的改善以及胎儿诊断技术的创新进展,使得对于因产前诊断出缺陷而复杂化的妊娠,必须采取多学科方法。胎儿治疗的概念,以前仅限于针对Rh疾病的宫内输血和诱导肺成熟,现在已扩展到对先天性肾积水、膈疝和骶尾部畸胎瘤进行开放性胎儿矫正。目前还在进一步探讨宫内造血干细胞移植以及产前基因治疗的可能性。对这些治疗干预措施的持续研究主要围绕提高其疗效以及确保母亲和未出生胎儿的安全展开。